EUVIMEDEUVIMED entdecken
Open Access

Ferroptosis surveillance: Insights from in vivo contexts

Alec J Vaughan, Mario Palma, Jessalyn M Ubellacker, Thales Papagiannakopoulos

Ferroptosis and Oxidative Stress · 2025

DOI: 10.70401/fos.2026.0021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2025. Verfasst von Alec J Vaughan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis has emerged over the past decade as a compelling therapeutic avenue for cancer, prompting intense interest in strategies that selectively induce or inhibit this form of cell death. Although substantial progress has been made in identifying genes that regulate ferroptosis sensitivity and in developing small-molecule modulators, it remains unclear which molecular targets offer the greatest therapeutic potential in specific tissues and contexts. Here, we highlight fundamental differences between in vitro and in vivo ferroptosis modulation, with emphasis on the integration of different techniques, mouse models, and how the tumor microenvironment shapes two major ferroptosis surveillance pathways: glutathione peroxidase 4 and ferroptosis suppressor protein 1. We propose that integrating in vivo biological constraints and microenvironmental complexity is essential for the rational design and successful translation of ferroptosis-targeted therapies.

Schlagwörter

Stichwörter der Autor:innen

FerroptosisGPX4–FSP1 axisin vivo modelingmicroenvironment

Autor:innen und Institutionen

  • Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA.
  • Vilcek Institute of Graduate Biomedical Sciences, New York University Grossman School of Medicine, New York, NY 10016, USA.
  • Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA.
  • Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016, USA.

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Vaughan, A. J., Palma, M., Ubellacker, J. M., & Papagiannakopoulos, T. (2025). Ferroptosis surveillance: Insights from in vivo contexts. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0021

Vancouver

Vaughan AJ, Palma M, Ubellacker JM, Papagiannakopoulos T. Ferroptosis surveillance: Insights from in vivo contexts. Ferroptosis and Oxidative Stress. 2025. doi:10.70401/fos.2026.0021

BibTeX
@article{Vaughan2025,
  author = {Vaughan, Alec J and Palma, Mario and Ubellacker, Jessalyn M and Papagiannakopoulos, Thales},
  title = {Ferroptosis surveillance: Insights from in vivo contexts},
  journal = {Ferroptosis and Oxidative Stress},
  year = {2025},
  doi = {10.70401/fos.2026.0021}
}
Kostenlos starten →